Disseminated cancer cells detected by immunocytology in lymph nodes of <scp>NSCLC</scp> patients are highly prognostic and undergo parallel molecular evolution

MLA

Felix Elsner, et al. “Disseminated Cancer Cells Detected by Immunocytology in Lymph Nodes of NSCLC Patients Are Highly Prognostic and Undergo Parallel Molecular Evolution.” The Journal of Pathology, vol. 258, Sept. 2022, pp. 250–63. EBSCOhost, https://doi.org/10.1002/path.5996.

APA

Felix Elsner, Martin Hoffmann, Rezan Fahrioglu‐Yamaci, Zbigniew Czyz, Giancarlo Feliciello, Tobias Mederer, Bernhard Polzer, Steffi Treitschke, Petra Rümmele, Florian Weber, Hellmuth Wiesinger, Tobias Robold, Zsolt Sziklavari, Wulf Sienel, Hans‐Stefan Hofmann, & Christoph A Klein. (2022). Disseminated cancer cells detected by immunocytology in lymph nodes of NSCLC patients are highly prognostic and undergo parallel molecular evolution. The Journal of Pathology, 258, 250–263. https://doi.org/10.1002/path.5996

Chicago

Felix Elsner, Martin Hoffmann, Rezan Fahrioglu‐Yamaci, Zbigniew Czyz, Giancarlo Feliciello, Tobias Mederer, Bernhard Polzer, et al. 2022. “Disseminated Cancer Cells Detected by Immunocytology in Lymph Nodes of NSCLC Patients Are Highly Prognostic and Undergo Parallel Molecular Evolution.” The Journal of Pathology 258 (September): 250–63. doi:10.1002/path.5996.